The Neutrino Donut will be attending the BIO Conference in San Diego in June. We are seeking partnerships to advance technologies through the SBIR space. We are looking to set up meeting with tech transfer groups, venture capital groups, and corporate venture groups. We believe there is a major value add to these organizations by getting involved in startups that will have undiluted funding to advance the technology and technical and commercialization validation process, making these startups more interesting to these groups. Let’s chat in San Diego!

#BIO2022 #neutrinodonut #sbir #autm #commercialization #nih

Dr. Mahajan has written several volumes on the startup infrastructure in the third world. His insights have been interesting and I commend his books to you.

Attached is his new book announcement.

Greetings from the University of Texas at Austin 

My next book on developing countries titled, Digital Leapfrogs: How Technology is Reshaping Consumer Markets in India, is being released by HaperCollins (see attachment). For comparison, the book also includes my interviews and market visits in Kenya. 

FICCI (Federation of Indian Chambers of Commerce and Industry) is hosting the book launch event on April 13 in New Delhi in collaboration with the Internet and Mobile Association of India.

More information can be found on Amazon. 

If convenient and appropriate, please do share information with your friends, collogues and social media followers who may be interested in this topic.

I thank you .

Best, Vijay

Vijay Mahajan, PhD 

John P. Harbin Centennial Chair in Business

Department of Marketing 

McCombs School of Business

University of Texas at Austin 

The Neutrino Donut notes levels of scientific cooperation in the nuclear fusion industry. The Donut is currently working on multiple commercialization projects in this space. We note this update from Axios on the Russia embargo and nuclear fusion projects with a major research player – Commonwealth Fusion.

https://www.axios.com/sanctions-threaten-commonwealth-supply-chain-cbd6bc83-af39-4a1c-a922-271877354e06.html

Scoop: Russia sanctions threaten Commonwealth’s supply chain

International sanctions and calls for corporate divestment of Russian assets threaten to disrupt the supply chain of Commonwealth Fusion Systems, Axios has learned.

Why it matters: CFS raised $1.8 billion in Series B funding in December for its unique fusion reactor design, a central ingredient of which is made by SuperOx, a Russian company with production facilities located in Moscow and Japan.

• That round was propelled by a “major advance” announced three months earlier: the creation of “colossally powerful” superconducting magnets that are crucial to containing the fusion reaction in Commonwealth’s reactor.
• The breakthrough was making those magnets with high temperature superconducting (HTS) tape — long ribbons of material that together can stretch over 3,000 miles.
• Nuclear fusion promises to unlock zero-emissions electricity, with fewer of the safety or security concerns than traditional nuclear fission.

What’s happening: CFS is building HTS tape into as many as 18 magnets, allowing it to achieve a fusion reaction within a far smaller, cheaper structure — and therefore dramatically lower its cost.

• “The first three years of the company was focused on building and proving that this magnet works,” CFS spokesperson Kristen Cullen tells Axios. “This magnet essentially unlocks our path to commercial fusion.”
• SuperOx, which is based in Moscow, is believed to be a key producer of HTS tape, and Cullen confirms to Axios that SuperOx is a supplier. However, she declined to state how much of the material was supplied by SuperOx alone or how many other companies make the specialized material.

Of note: SuperOx was founded by Russian oil magnate Andrey Vavilov.

• While CFS is “almost entirely funded by private sources,” Cullen tells Axios, the company has received taxpayer funding in the form of federal grants “for research in collaboration with national labs.”

What they’re saying: Even as companies around the world stop doing business with Russian firms, CFS has declined to confirm whether it will stop sourcing the material from SuperOx.

• CFS, though, says it was diversifying its supply of HTS tape before Russia’s invasion of Ukraine.
• Cullen acknowledged that the ongoing crisis is accelerating that move. “This has long been a focus of the company, but of course there is now more urgency,” she says.

Between the lines: The potential bottleneck in HTS supply exposes the sharp difference in approach by fusion developers.

• CFS says that its fusion reactor will achieve net output — producing more power than it consumes — by 2025, and that that deadline hasn’t changed.
• Other developers are relying on more established materials and supply chains. CFS adopted a novel method — one that won over investors last year, but potentially has now exposed the company to a unique vulnerability.

Alan Neuhauser co-authors the Axios Pro Climate deals newsletter. Sign up now.

Arts and sciences are key to the growth of businesses. Combining knowledge in these space expands the problem solving skills of the individuals. The Neutrino Donut is learning to play the mandolin. Jazz and blues are a focus.

The Donut will provide mentoring services to various universities, seeking to advance their technologies. These services are based on helping startups understand the commercialization ecosystem.

The Neutrino Donut will continue to provide support for SBIR grants under the NOAA program. We will be seeking market entry strategies for these new technologies.

The Neutrino Donut will continue commercialization projects for Department of Energy projects. Multiple topic areas will be covered.

Writing the Aims for your project is key to developing your commercialization strategy. The Donut recently noted a posting which best described how to write the Aim. You need to have the Title, Experimental Strategy, and Outcome or Impact.

Here is an example of the Aims section:

(Title) Aim 1 will establish an innovative mouse model for HTLV-1 Tax tumorigenesis. (Experimental Strategy) Targeting vectors containing silenced wild-type or mutant Tax genes will be knocked in to the Rosa26 locus of C57BL/6 mice. These mice will then be crossed with homozygous Lck-CRE mice, thereby excising the stop cassette and (Outcome or Impact) generating mice that express wild-type or mutant Tax proteins specifically in T cells.

(Title) Aim 2 will examine the effect of mutations that disable specific biological functions of Tax on Tax-mediated tumorigenesis. Tax can bind to and regulate the activity of members of the SRF, CREB, NF-kB and PBM protein families, each of which has been implicated in oncogenesis. (Experimental Strategy) Mice established in Aim 1 will allow us to compare for the first time the tumorigenic potential of wild-type and mutant Tax proteins in an (Outcome or Impact) effort to identify pathways that are required for Tax tumorigenesis. 

All three items should be noted in your description of the Aim. For more information, check out the author’s posting at https://www.biosciencewriters.com/NIH-Grant-Applications-The-Anatomy-of-a-Specific-Aims-Page.aspx.

The Neutrino Donut has been providing analysis of NIH commercialization reports as well as writing more of them. The key area is the definition of the market and having a cohesive message throughout the document.